KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Assets (2018 - 2025)

Esperion Therapeutics (ESPR) has disclosed Return on Assets for 8 consecutive years, with 0.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 4.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2025, down 4.0%, and an annual FY2025 reading of 0.06%, up 13.0% over the prior year.
  • Return on Assets was 0.06% for Q4 2025 at Esperion Therapeutics, up from 0.3% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q4 2024 and bottomed at 1.22% in Q3 2021.
  • Average Return on Assets over 5 years is 0.62%, with a median of 0.73% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -87bps in 2021, then skyrocketed 99bps in 2024.
  • Year by year, Return on Assets stood at 0.9% in 2021, then grew by 6bps to 0.84% in 2022, then decreased by -19bps to 1.0% in 2023, then skyrocketed by 99bps to 0.01% in 2024, then plummeted by -298bps to 0.06% in 2025.
  • Business Quant data shows Return on Assets for ESPR at 0.06% in Q4 2025, 0.3% in Q3 2025, and 0.32% in Q2 2025.